$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Using the SMA as a consistent anatomical landmark, intestinal autonomic nerve bundles can be identified as thin, pearly-white structures running parallel to the vessel. Based on their anatomical position relative to the SMA, the superior bundle was designated as the presumed parasympathetic bundle and the inferior bundle as the presumed sympathetic bundle (Figure 1A,D). A positive intraoperative result is achieved when the target bundle is clearly visualized and completely interrupted, with no residual fibers bridging the transection plane. Any milky or whitish fluid occasionally observed at the transection site was not considered confirmatory evidence of successful nerve transection, because a similar appearance may arise from disruption of surrounding lymphatic or connective tissue. Successful denervation was therefore evaluated by combined anatomical observation and downstream validation (Figure 1B,C,E). Suboptimal intraoperative outcomes include difficulty distinguishing the bundle from surrounding connective tissue, incomplete transection with residual fibers bridging the cut ends, or bleeding that obscures the surgical field, each of which may lead to partial denervation and variable downstream validation.
To confirm functional disruption of gut-directed autonomic projections, retrograde tracing was performed using fluorescent cholera toxin B (CTB). Mice were anesthetized, and abdominal surgery was performed as described above. Then, 0.5 µL of 1% CTB-555 in PBS containing 0.1% Fast Green was administered as a single focal submucosal injection into the proximal colon adjacent to the cecum using a microsyringe. The injection site was washed several times with PBS to minimize spillover of tracer to adjacent tissues, and the abdominal wall was closed with sutures. Successful injection was defined by localized retention of Fast Green within the bowel wall without visible leakage onto the serosal surface or adjacent tissues; representative successful and failed injections are shown in Figure 2. Two days post-injection, the relevant ganglia were dissected (NG for parasympathetic projections; CG for sympathetic projections) and fixed overnight in 4% PFA, embedded in OCT, cryosectioned at 10 µm, counterstained with DAPI, and imaged by confocal microscopy11.
In this paradigm, successful selective transection is indicated by the absence of CTB-555 labeling in the upstream ganglion (Figure 3A,C,E), consistent with interruption of autonomic projections. In contrast, sham-operated mice are expected to exhibit positive CTB-555 labeling in the corresponding ganglion, because the nerve branch is exposed and separated but not transected, preserving intact autonomic projections. (Figure 3B,D,F). Therefore, weak or absent labeling in sham-operated mice typically indicates a tracer-related technical issue (e.g., insufficient injection into the bowel wall, leakage, spillover, or suboptimal tracer uptake or transport), whereas residual labeling in transected animals suggests incomplete transection or sparing of collateral fibers. These scenarios can be distinguished from true biological variability by verifying injection quality, standardizing the post-injection interval, and maintaining consistent sectioning and imaging settings12,13.
To further support pathway-specific denervation, colon tissues were collected after transection and subjected to immunohistochemical analysis. Following transection of the presumed sympathetic bundle, TH immunoreactivity was markedly reduced in both the proximal and distal colon, indicating decreased sympathetic innervation (Figure 4). Following transection of the presumed parasympathetic bundle, ChAT immunoreactivity was markedly reduced in both the proximal and distal colon, indicating decreased cholinergic parasympathetic input (Figure 5). These findings provide additional histological support for the effectiveness of the denervation procedure.
Together, anatomical confirmation of nerve interruption at the SMA and loss of CTB-555 retrograde labeling in the pathway-specific ganglion provide a practical range of outcomes for interpreting denervation efficacy, spanning complete, partial, and failed denervation.

Figure 1: Selective transection of intestine-innervating autonomic nerves in a murine model. (A) Representative operative view after exposure of the superior mesenteric artery (SMA), showing two white, translucent nerve bundles running parallel to the vessel. The white arrow indicates the parasympathetic branch on the superior aspect of the SMA, and the yellow arrow indicates the sympathetic branch on the inferior aspect of the SMA. (B) After transection of the inferior sympathetic branch, only the superior parasympathetic branch remains, as indicated by the white arrow. (C) After subsequent transection of the superior parasympathetic branch, only the SMA remains visible, as indicated by the arrow. (D) Representative operative view from another mouse, with the white arrow indicating the parasympathetic branch. (E) After transection of the superior parasympathetic branch, only the inferior sympathetic branch remains, as indicated by the yellow arrow. Please click here to view a larger version of this figure.

Figure 2: Intramural injection into the proximal colon for retrograde tracing. (A) The cecum is gently exteriorized from the abdominal cavity to expose the proximal colon. (B) The proximal colon is lifted carefully with microforceps, and the tracer solution is injected into the intestinal wall using a microsyringe. (C) Representative image of a successful injection, showing that the Fast Green dye remains localized within the submucosal layer without obvious leakage. (D) Representative image of an unsuccessful injection, showing leakage of the Fast Green dye into the intestinal lumen. Please click here to view a larger version of this figure.

Figure 3: CTB-555 retrograde tracing validates selective intestinal autonomic denervation. Mice received a focal submucosal colonic injection of CTB-555 (red) for retrograde tracing; nuclei were counterstained with DAPI (blue). (A) Selective parasympathetic transection group; retrograde labeling was evaluated in the left NG. (B) Sham-operated control corresponding to (A), retrograde labeling was evaluated in the NG. (C) Selective parasympathetic transection group; retrograde labeling was evaluated in the right NG. (D) Sham-operated control corresponding to (C), retrograde labeling was evaluated in the NG. (E) Selective sympathetic transection group; retrograde labeling was evaluated in the CG. (F) Sham-operated control corresponding to (E); retrograde labeling was evaluated in the CG. Scale bars = 50 µm. Please click here to view a larger version of this figure.

Figure 4: Tyrosine hydroxylase (TH) immunofluorescence staining in the proximal and distal colon after sympathectomy. Representative immunofluorescence images of the proximal colon and distal colon from the sympathectomy group and the sham operation group. TH is shown in green, and nuclei are counterstained with DAPI (blue). The upper panels show the sham operation group, and the lower panels show the sympathectomy group. The left panels represent the proximal colon, and the right panels represent the distal colon. Scale bars = 100 µm. Please click here to view a larger version of this figure.

Figure 5: ChAT immunofluorescence staining in the proximal and distal colon after parasympathectomy. Representative immunofluorescence images of the proximal colon and distal colon from the parasympathectomy group and the sham operation group. ChAT is shown in green, and nuclei are counterstained with DAPI (blue). The upper panels show the sham operation group, and the lower panels show the parasympathectomy group. The left panels represent the proximal colon, and the right panels represent the distal colon. Scale bars = 100 µm. Please click here to view a larger version of this figure.
Supplementary File 1: Troubleshooting guide for common intraoperative complications.Please click here to download this file.